AIMC Topic: Ovarian Diseases

Clear Filters Showing 1 to 1 of 1 articles

Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.

Journal of the National Cancer Institute Dec 1, 2017
BACKGROUND: Aromatase inhibitors (AIs) are given as adjuvant therapy for hormone receptor-positive breast cancer in postmenopausal women, also to those with chemotherapy-induced ovarian function failure. The current analysis reports on endocrine data...
Humans Prognosis Female Adult Breast Neoplasms Middle Aged Case-Control Studies Estradiol Recovery of Function Randomized Controlled Trials as Topic Aromatase Inhibitors Anastrozole Antineoplastic Agents, Hormonal Chemotherapy, Adjuvant Clinical Trials, Phase III as Topic Ovarian Diseases Ovary Tamoxifen
View on PubMed DOI
Popular Topics
Recent Journals